Sign up to our newsletter
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
LATEST ALERTS
View all Cannabis and cannabinoids in Israel
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Daily regulatory updates of legal changes in the cannabis sector, including monthly compilations
30th October 2023
Israel: The Medical Cannabis Unit published a warning against the use of cannabis after traumatic events. The warning emphasises that cannabis has not been proven effective for the acute phase following trauma and may even be harmful. It recommends that cannabis treatment is only deemed appropriate for chronic conditions, and only after talk therapies or research-based drug treatments.19th October 2023
Israel: Today the Ministry of Health published for public consultation a proposal to defer the effective date of the amendment to the Dangerous Drugs Ordinance from 29th December 2023 to 29th March 2024. The Health Committee of the Knesset (parliament) and the health minister signed the amendments in June 2023, imposing new rules for licensing medical cannabis for patients, producers and growers; simplifying the licensing process; and reducing approval timelines. The public should submit comments before 2nd November 2023.
9th October 2023
- Israel: The Ministry of Health has issued an order stating that patients and businesses with medical cannabis licences that have expired or will expire within the next month who can’t renew due to the current situation in the country will receive an automatic renewal for three months from the actual expiry date. A copy of the extension will be sent to the licensees by email.
3rd October 2023
- Israel: The Medical Cannabis Unit invites the public to submit their comments to the committee reviewing phytocannabinoids. The committee will formulate decisions regarding the exclusion of products or parts of the cannabis plant that have an intoxicating psychoactive effect from the definition of “dangerous drug” in the Dangerous Drugs Ordinance. The committee will not discuss excluding THC from the definition of a dangerous drug. The public should send their comment by email before 29th October 2023.
15th September 2023
- Israel: The Medical Cannabis Unit has published for public consultation a draft table on the categories of medical cannabis products it has approved. The table lists the products, their categories, and their THC, CBD and cannabinol (CBN) concentrations. The consultation ends on 24th September. Israel’s new reform on the use of medical cannabis laid down new rules, with products classified by categories, and published on the Medical Cannabis Unit website, to ensure precise concentration indications to combat high THC consumption and non-medical marketing in Israeli pharmacies.
16th August 2023
- Israel: The Ministry of Health published the outline of its new reform on the use of medical cannabis last week. The new rules lift some of the regulatory restrictions on growers and producers of medical cannabis, ease the licensing process, and reduce the timeline for approval to 14 days. In addition, patients with specific conditions like cancer, Crohn’s disease, dementia, autism, multiple sclerosis and HIV can now get prescriptions from their doctors without obtaining a licence. The new regulation will come into effect in December 2023.
29th May 2023
- Israel: The Ministry of Health has again issued a warning against the use of e-cigs containing synthetic cannabinoids (ADB-BUTINACA and MDMB-4en-Pinaca) known as “Nice Guy”. They are sold illegally under the brand names RM Premium, Snoop Dogg, Fume Orjoy, Premium Vape, and The Bulldog and cause severe mental and physical effects such as psychosis, anxiety and panic attacks, cerebral edema, kidney damage, heart damage and bleeding in the digestive system.
9th January 2023
- Israel: The Ministry of Health has issued a warning against the use of e-cigs containing synthetic cannabinoids (ADB-BUTINACA and MDMB-4en-Pinaca) known as “Nice Guy”, which is sold illegally under the brand names Premium Vape, Snoop Dogg, and The Bulldog and causes severe mental and physical effects such as psychosis, hallucinations, anxiety, panic attacks, bleeding, cerebral oedema, kidney damage and damage to the heart, press reports.
2nd November 2022
Israel: With most votes counted after yesterday’s general election, the Likud party led by former prime minister Benjamin Netanyahu appeared set to unseat premier Yair Lapid and return Netanyahu to power. While Netanyahu has previously backed the legalisation of recreational cannabis, his right-wing bloc, which also includes the Religious Zionist Party (RZP), the conservative United Torah Judaism (UTJ), and the religious Shas party, may not be supportive of such an approach.
9th September 2022
- Israel: The Ministry of Health has opened a public consultation to change the current system on the prescription of medical cannabis, which requires a prescription and a special licence. The ministry seeks to ease the bureaucratic burden by dropping the licence requirement. The period for comments will be open until 13th September. Comments need to be sent to mishpatitjer@moh.gov.il.
1st March 2022
- Israel: CBD will no longer be considered a dangerous drug. The Ministry of Health has decided to exclude CBD from the Dangerous Drugs Ordinance as long as its THC content is below 0.3%. The Ministry has also decided to create a working group that will analyse with CBD experts the regulatory changes taking place around the world in order to keep Israeli regulation up-to-date.
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
